Click to view your profile
Click to search for condition or expert
Click to open main menu
HER-2 Positive Breast Cancer Latest Advances
Find the Latest Research About HER-2 Positive Breast Cancer
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 02/19/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
See more filters
Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain.
Condition:
HER2 Positive Breast Cancer
Journal:
Current oncology (Toronto, Ont.)
Treatment Used:
Neoadjuvant Pertuzumab
Number of Patients:
0
Published:
December 22, 2022
VIEW PUBLICATION
Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis.
Condition:
HER2 Positive Breast Cancer (BC)
Journal:
Systematic reviews
Treatment Used:
Lapatinib vs. Lapatinib plus Trastuzumab vs. Trastuzumab
Number of Patients:
0
Published:
December 10, 2022
VIEW PUBLICATION
Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study.
Condition:
Women with HER2-Positive Breast Cancer
Journal:
Future oncology (London, England)
Treatment Used:
Trastuzumab and Pertuzumab vs. Trastuzumab and Pertuzumab Plus Chemotherapy
Number of Patients:
376
Published:
October 27, 2022
VIEW PUBLICATION
Adjuvant therapy for HER2 positive pT1a-b pN0 breast cancer: A single center cohort study.
Condition:
HER2 Positive pT1a-b pN0 Breast Cancer
Journal:
Medicine
Treatment Used:
Adjuvant Therapy
Number of Patients:
168
Published:
June 27, 2022
VIEW PUBLICATION
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis.
Condition:
HER2 Positive Metastatic Breast Cancer (MBC)
Journal:
BMC cancer
Treatment Used:
T-DM1
Number of Patients:
0
Published:
June 07, 2022
VIEW PUBLICATION
Systemic management of brain metastases in HER2+ breast cancer in 2022.
Condition:
Brain Metastases (BrMs) in HER2+ Breast Cancer
Journal:
Clinical advances in hematology & oncology : H&O
Treatment Used:
Systemic Therapies
Number of Patients:
0
Published:
May 17, 2022
VIEW PUBLICATION
A comparison of local therapy alone with local plus systemic therapy for stage I pT1aN0M0 HER2+ breast cancer: A National Cancer Database analysis.
Condition:
Stage I pT1aN0M0 HER2+ Breast Cancer
Journal:
Cancer
Treatment Used:
Local Therapy Alone vs. Local Plus Systemic Therapy
Number of Patients:
8948
Published:
April 01, 2022
VIEW PUBLICATION
The Efficacy of Combined Use of Pertuzumab and Trastuzumab-Based Neoadjuvant Chemotherapy for HER2 Positive Breast Cancer.
Condition:
HER2 Positive Breast Cancer
Journal:
Gan to kagaku ryoho. Cancer & chemotherapy
Treatment Used:
Pertuzumab and Trastuzumab-Based Chemotherapy
Number of Patients:
11
Published:
January 20, 2022
VIEW PUBLICATION
Local Therapy Outcomes and Toxicity From the ATEMPT Trial (TBCRC 033), a Phase II Randomized Trial of Adjuvant T-DM1 vs. TH in Women With Stage I HER2 Positive Breast Cancer.
Condition:
Women with Stage I HER2 Positive (HER2+) Breast Cancer
Journal:
International journal of radiation oncology, biology, physics
Treatment Used:
Radiation Therapy (RT)
Number of Patients:
497
Published:
October 27, 2021
VIEW PUBLICATION
De-Escalation of Radiation Therapy in Patients with cT1-T2 (< 3 cm) N0 HER2+ Breast Cancer Treated With Neoadjuvant Systemic Therapy With Pathologic Complete Response at the Time of Breast Conserving Surgery.
Condition:
cT1-T2 N0 HER2+ Breast Cancer
Journal:
International journal of radiation oncology, biology, physics
Treatment Used:
De-Escalation of Radiation Therapy
Number of Patients:
4842
Published:
October 27, 2021
VIEW PUBLICATION
T-DM1 Increases the Risk of SRS-Induced Radiation Necrosis in Her2+ Breast Cancer.
Condition:
HER2+ Breast Cancer-Related Brain Metastases (BrM)
Journal:
International journal of radiation oncology, biology, physics
Treatment Used:
Trastuzumab Emtansine (T-DM1)
Number of Patients:
67
Published:
October 27, 2021
VIEW PUBLICATION
Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data.
Condition:
Locally Advanced HER2 Positive Breast Cancer
Journal:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Treatment Used:
Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy
Number of Patients:
63
Published:
September 26, 2021
VIEW PUBLICATION
Showing 1-12 of 33
Next
Last Updated: 02/19/2023